General contact

Head Office
Novartis International AG
CH-4002 Basel
Switzerland

+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 - 17:00, GMT+1
(Central European Time)

Investors

Novartis International AG
Investor Relations
P.O. Box
CH-4002 Basel
Switzerland

+41 61 324 79 44

Media

Global Media Relations
Eric Althoff
Basel, Switzerland

+41 61 324 7999

Reporting side effects

Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine.

Reporting side effects

pane 4 content

Patient group support

Novartis interacts with many patient groups. These groups play a crucial role by informing and supporting patients, as well as safeguarding the rights of patients and caregivers. Further, patient groups provide pharmaceutical companies with important advice from their own perspective. Interacting with patient organizations enables Novartis to learn about unmet patient needs, and this information can guide us in the development of new medicines. In all our interactions with patient groups, we are committed to working ethically and transparently while respecting their integrity. With regards to the disclosure of patient group support, Novartis is fully compliant with all legal and statutory requirements as a minimum standard in a given country.

We commit to disclose the names of patient groups that have received funding or non-monetary support from Novartis as well as the purpose of this support in the US and for international groups. This list is updated annually. As member of the European Federation of Pharmaceutical Industries and Associations (EFPIA), Novartis is complying with the amended (June 2011) Code of Practice on Relationships between the Pharmaceutical Industry and Patient Organizations and is thus disclosing the monetary value of its support to European patient organizations in EFPIA-member countries during the year 2012. Novartis fully recognizes that it has many common interests with patient organizations which represent and/or support the needs of patients and/or caregivers. Novartis endorses the EFPIA Code ensuring that its relationships with patient organizations take place in an ethical and transparent manner.

EFPIA members

  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czech Republic
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Malta
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Russia
  • Serbia
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • Ukraine
  • United Kingdom
  • European associations
  • International associations registered in Europe

Europe non-members

  • Albania
  • Austria
  • Bosnia-Hercegovina
  • Bulgaria
  • Czech Republic
  • Finland
  • Germany
  • Italy
  • Macedonia
  • Poland
  • Romania
  • Slovenia
  • Spain
  • United Kingdom